[go: up one dir, main page]

MA23587A1 - Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme - Google Patents

Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Info

Publication number
MA23587A1
MA23587A1 MA23930A MA23930A MA23587A1 MA 23587 A1 MA23587 A1 MA 23587A1 MA 23930 A MA23930 A MA 23930A MA 23930 A MA23930 A MA 23930A MA 23587 A1 MA23587 A1 MA 23587A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
treatment
need
related syndrome
Prior art date
Application number
MA23930A
Other languages
English (en)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23587A1 publication Critical patent/MA23587A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA23930A 1994-06-23 1995-05-16 Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme MA23587A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23587A1 true MA23587A1 (fr) 1995-12-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23930A MA23587A1 (fr) 1994-06-23 1995-05-16 Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Country Status (6)

Country Link
AU (1) AU2770895A (fr)
IL (1) IL114128A0 (fr)
MA (1) MA23587A1 (fr)
PE (1) PE41096A1 (fr)
WO (1) WO1996000070A1 (fr)
ZA (1) ZA955031B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220768A1 (fr) * 1996-03-13 1997-09-18 Yale University Traitements pour cesser de fumer impliquant l'utilisation de naltrexone et de composes associes
AU2340397A (en) * 1996-03-21 1997-10-10 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
ATE247951T1 (de) * 1996-05-13 2003-09-15 Novartis Consumer Health Sa Mundfreisetzungssystem
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
CA2369515A1 (fr) 1999-04-06 2001-03-29 Wm. Wrigley Jr. Company Formulations pharmaceutiques de gomme a macher
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
DE20018196U1 (de) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Erzeugnis aus Zuckerware für Raucherentwöhnung
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
WO2004104493A2 (fr) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Procede de regulation thermique uniforme d'un substrat ; unite de chauffage integree et unite d'administration de medicaments recourant a ce procede
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005046363A2 (fr) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Compositions a base de tabac
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2576961A1 (fr) 2004-08-12 2006-03-02 Alexza Pharmaceuticals, Inc. Dispositif de distribution de drogue par aerosol integrant des conditionnements thermiques actionnes par percussion
EP2121088B1 (fr) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
DK2654738T3 (en) * 2010-12-21 2018-07-23 Fertin Pharma As CHEESE GUM COMPOSITION COMPREHENSIVE CROSS-POLYACRYLIC ACID
WO2019152873A1 (fr) 2018-02-02 2019-08-08 Alexza Pharmaceuticals, Inc. Dispositif aérosol à condensation électrique
EP4208049A1 (fr) * 2020-09-03 2023-07-12 Nicoventures Trading Limited Compositions et procédés
CN115590855A (zh) * 2022-10-26 2023-01-13 江南大学（Cn） 一种降低尼古丁制品中尼古丁含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526L (fi) * 1990-08-23 1992-02-24 Wrigley W M Jun Co Tuggummi med laog fukthalt.

Also Published As

Publication number Publication date
WO1996000070A1 (fr) 1996-01-04
IL114128A0 (en) 1995-10-31
PE41096A1 (es) 1996-10-08
AU2770895A (en) 1996-01-19
ZA955031B (en) 1996-02-08

Similar Documents

Publication Publication Date Title
MA23587A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
MA23588A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
DE69619433D1 (de) Tabakrauchfilter und Verfahren zur Herstellung derselben
FI972781L (fi) Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä
EP0925046A4 (fr) Formulations topiques et methodes de traitement des douleurs hemorroidales
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI935827L (fi) Menetelmä ja laite kaasujen märkäpuhdistamiseksi
FI950587A7 (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
PT836390E (pt) Cigarro e metodo para o fabrico de cigarro para sistema electrico de fumar
FR2726191B1 (fr) Dispositif de traitement du syndrome d'apnee pendant le sommeil
FI955360A0 (fi) Absorboivan kappaleen päällysarkki ja menetelmä sen valmistamiseksi
DE69626920D1 (de) Tabakrauchfiltermaterial und Tabakrauchfilter hergestellt aus diesem Material
DE69003977D1 (de) Verfahren und Einrichtung zur Bestimmung des Stengelgehaltes von Tabak.
MA23586A1 (fr) Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
NO951175D0 (no) Sigarettfilter og fremgangsmåte for dets fremstilling
DE69306328D1 (de) Einrichtung zum automatischen Rauchen von Tabakrollen und zum Analysieren des Rauches
FI964227A7 (fi) Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
BR9001661A (pt) Artigo para fumantes e tratamento de tabaco
EP0750620A4 (fr) Composes de carbapeneme, compositions les contenant, et methodes de traitement associees
FI963264A7 (fi) Tromboksaani A2-välitteisten sairauksien ennaltaestoon ja hoitoon tarkoitettu aine
ITMI931359A0 (it) Procedimento e dispositivo per l'essiccamento di tabacco
BR9507375A (pt) Tratamento de superficies particuladas